SCHEMBL1723809

SCHEMBL1723809

COC(=O)/C=C\c1ccc(OCc2ccccc2)cc1F

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.57
MAP3K7 O43318 1/20 0.50
TAB1 Q15750 1/20 0.50
BACE1 P56817 4/20 0.49
GSK3B P49841 1/20 0.49
PTGER3 P43115 1/20 0.48
PTGDR Q13258 1/20 0.48
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
PKM P14618 1/20 0.47
APP P05067 1/20 0.47
MAPT P10636 1/20 0.47
MRGPRX4 Q96LA9 1/20 0.46
MAOB P27338 3/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PLA2G2D Q9UNK4 1/20 0.45
PTPN1 P18031 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL865803 1.00 HDAC8 (0.57) HDAC8MAP3K7TAB1BACE1GSK3B
SCHEMBL865802 1.00 HDAC8 (0.57) HDAC8MAP3K7TAB1BACE1GSK3B
SCHEMBL9199951 0.88 HDAC8 (0.59) HDAC8MAP3K7TAB1BACE1GSK3B
SCHEMBL865293 0.87 ALDH1A1 (0.61) HDAC8BACE1GSK3BPTGER3PTGDR
SCHEMBL2781980 0.87 ALDH1A1 (0.61) HDAC8BACE1GSK3BPTGER3PTGDR
SCHEMBL865294 0.87 ALDH1A1 (0.61) HDAC8BACE1GSK3BPTGER3PTGDR
SCHEMBL5524486 0.86 HDAC8 (0.58) HDAC8MAP3K7TAB1BACE1GSK3B
SCHEMBL5524484 0.86 HDAC8 (0.58) HDAC8MAP3K7TAB1BACE1GSK3B
SCHEMBL18559977 0.85 HDAC8 (0.69) HDAC8BACE1GSK3BKDM4EALDH1A1
SCHEMBL8070061 0.81 HDAC8 (0.50) HDAC8KDM4EALDH1A1MAPTPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2406247-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS Prosidion Limited (GB) 2012-01-18 EP disclosed
WO-2010103333-A1 COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2010-09-16 WO disclosed